Key Calls (Tuesday): Upgrades, Downgrades, & Initiations

Via Bloomberg:

upgrade

  • Agrium (AGU CN) raised to outperform at Cowen, PT $109
  • Allison Transmission (ALSN) raised to buy at Citi
  • Amicus (FOLD) raised to outperform at Baird
  • Bonterra Energy (BNE CN) raised to outperform at Raymond James, PT C$31
  • CF Industries (CF) raised to market perform at Cowen, PT $31
  • Calithera Biosciences (CALA) raised to neutral at Citi
  • Columbia Property (CXP) raised to outperform at Oppenheimer, PT $26
  • IMAX China (1970 HK) raised to hold at Deutsche Bank
  • MKS Instruments (MKSI) raised to buy at Dougherty
  • Mosaic (MOS) raised to market perform at Cowen, PT $29
  • Potash (POT CN) raised to market perform at Cowen, PT $18
  • Silgan (SLGN) raised to outperform at BMO, PT $65
  • TELEVISA (TLEVICPO MM) raised to buy at BofAML
  • Tableau (DATA) raised to buy at Citi, PT $64

downgrade

  • AMN Healthcare (AMN) cut to market perform at Avondale, PT $40
  • Apple (AAPL) cut to equal-weight at Barclays, PT $117
  • Cross Country Health (CCRN) cut to market perform at Avondale
  • DineEquity (DIN) cut to neutral at Nomura
  • Energous (WATT) cut to market perform at Oppenheimer
  • Essex Property (ESS) cut to market perform at JMP
  • Humana (HUM) cut to hold at Stifel
  • KB Home (KBH) cut to underperform at Raymond James
  • MicroStrategy (MSTR) cut to neutral at Citi
  • Milestone Apartments REIT (MST-U CN) cut to hold at Desjardins, PT C$21.50
  • NantKwest (NK) cut to hold at Jefferies, PT $6
  • Performance Food (PFGC) cut to equal-weight at Barclays, PT $25

initiation

  • AGCO (AGCO) rated new buy at Berenberg, PT $72
  • Almost Family (AFAM) rated new neutral at BofAML, PT $49
  • Deere (DE) rated new sell at Berenberg, PT $90
  • FS Investment (FSIC) rated new neutral at Janney, PT $10
  • HealthEquity (HQY) rated new overweight at Keybanc, PT $60
  • Hill-Rom (HRC) rated new buy at Stifel, PT $70
  • Matador Resources (MTDR) rated new outperform at Raymond James, PT $31
  • Pharming Group Resumed Buy at Roth Capital
  • TechnipFMC (FTI) rated new buy at Goldman, PT $40
Advertisements

Speak On It